This should be another big week for EXL as news slowly drips out regarding the Farm Bill. Keep your eye on movement leading into Friday this week. Looking for price to hold new all time highs by mid week to confirm another possible BULLISH move on the more quieter news as WHO expert committee on drug dependence makes an announcement about the rescheduling of CBD & THC which is another massive foot print in where things are heading next year...
I would be severely disappointed if Elixinol did not pursue Australian activities in the MC space. Their revenue does so well because of their CBD products over there so to have them here in australia, against competition or not, you let results do the talking. Their team in the US are industry experts in all aspects so to see that passed onto people here on our soil would be great.
Australian MC license will be the icing on the cake and IMO we will see it if not before the years end then with in Q1 and that is what will light things up. Investors are looking for an Australian play in cultivation that does what they say they will unlike many others.
I look forward to seeing this company with one of Australia's biggest facilities over the next few years and employing many.and sticking to their prospectus as they have so far.
Enjoy the week shareholders, I have a feeling it is going to an exciting one.
Ann: Elixinol Global raises A$40m to accelerate international gro, page-79
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.605M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $1.605K | 321.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 6265944 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 14532474 | 10 |
View Market Depth
| Last trade - 15.57pm 25/11/2024 (20 minute delay) ? |
| EXL (ASX) Chart |
